Jang G, Park R, Esteva E, Hsu P, Feng J, Upadhaya S
J Exp Med. 2025; 222(6).
PMID: 40072317
PMC: 11899982.
DOI: 10.1084/jem.20240587.
Wu X, Liu W, Wang Y, Wang K, Xing B
Cancer Med. 2024; 13(19):e70168.
PMID: 39377605
PMC: 11459679.
DOI: 10.1002/cam4.70168.
Hindul N, Abbott L, Adan S, Straatman K, Fry A, Hirota K
J Biol Chem. 2024; 300(6):107409.
PMID: 38796063
PMC: 11234024.
DOI: 10.1016/j.jbc.2024.107409.
Tyagi I, Tsui H, Chen S, Li X, Mat W, Khan M
Cell Div. 2024; 19(1):3.
PMID: 38341593
PMC: 10858565.
DOI: 10.1186/s13008-024-00109-x.
Ganguli S, Wyatt T, Nyga A, Lawson R, Meyer T, Baum B
Curr Biol. 2023; 33(13):2728-2741.e3.
PMID: 37343559
PMC: 7614879.
DOI: 10.1016/j.cub.2023.05.061.
DDX3 acts as a tumor suppressor in colorectal cancer as loss of DDX3 in advanced cancer promotes tumor progression by activating the MAPK pathway.
Shen L, Zhang J, Xu M, Zheng Y, Wang M, Yang S
Int J Biol Sci. 2022; 18(10):3918-3933.
PMID: 35844798
PMC: 9274493.
DOI: 10.7150/ijbs.73491.
FOSL1 promotes proneural-to-mesenchymal transition of glioblastoma stem cells via UBC9/CYLD/NF-κB axis.
Chen Z, Wang S, Li H, Luo H, Wu X, Lu J
Mol Ther. 2022; 30(7):2568-2583.
PMID: 35351656
PMC: 9263249.
DOI: 10.1016/j.ymthe.2021.10.028.
hnRNPA1/UP1 Unfolds G-Quadruplexes and Feeds a Regulatory Axis Controlling Gene Expression.
Ferino A, Marquevielle J, Choudhary H, Cinque G, Robert C, Bourdoncle A
ACS Omega. 2021; 6(49):34092-34106.
PMID: 34926957
PMC: 8675163.
DOI: 10.1021/acsomega.1c05538.
Skeletal muscle metastasis with bone metaplasia from colon cancer: A case report and review of the literature.
Guo Y, Wang S, Zhao Z, Li J, Shang A, Li D
World J Clin Cases. 2021; 9(30):9285-9294.
PMID: 34786415
PMC: 8567510.
DOI: 10.12998/wjcc.v9.i30.9285.
The Importance of Being PI3K in the RAS Signaling Network.
Cuesta C, Arevalo-Alameda C, Castellano E
Genes (Basel). 2021; 12(7).
PMID: 34356110
PMC: 8303222.
DOI: 10.3390/genes12071094.
Ras Isoforms from Lab Benches to Lives-What Are We Missing and How Far Are We?.
Nair A, Kubatzky K, Saha B
Int J Mol Sci. 2021; 22(12).
PMID: 34204435
PMC: 8233758.
DOI: 10.3390/ijms22126508.
The Crossroads between RAS and RHO Signaling Pathways in Cellular Transformation, Motility and Contraction.
Soriano O, Alcon-Perez M, Vicente-Manzanares M, Castellano E
Genes (Basel). 2021; 12(6).
PMID: 34071831
PMC: 8229961.
DOI: 10.3390/genes12060819.
Ras Signaling in Breast Cancer.
Moon A
Adv Exp Med Biol. 2021; 1187:81-101.
PMID: 33983574
DOI: 10.1007/978-981-32-9620-6_4.
Myosin Motors: Novel Regulators and Therapeutic Targets in Colorectal Cancer.
Naydenov N, Lechuga S, Huang E, Ivanov A
Cancers (Basel). 2021; 13(4).
PMID: 33670106
PMC: 7916823.
DOI: 10.3390/cancers13040741.
Identification of Radil as a Ras binding partner and putative activator.
Choi B, Kou Z, Colon T, Chen C, Chen Y, Dai W
J Biol Chem. 2021; 296:100314.
PMID: 33482197
PMC: 7949112.
DOI: 10.1016/j.jbc.2021.100314.
Genomic Amplification and Functional Dependency of the Gamma Actin Gene in Uterine Cancer.
Richter C, Mayhew D, Rennhack J, So J, Stover E, Hwang J
Int J Mol Sci. 2020; 21(22).
PMID: 33217970
PMC: 7698702.
DOI: 10.3390/ijms21228690.
4-Hydroxyacetophenone modulates the actomyosin cytoskeleton to reduce metastasis.
Bryan D, Stack M, Krysztofiak K, Cichon U, Thomas D, Surcel A
Proc Natl Acad Sci U S A. 2020; 117(36):22423-22429.
PMID: 32848073
PMC: 7486788.
DOI: 10.1073/pnas.2014639117.
Association of RAS Mutation Location and Oncologic Outcomes After Resection of Colorectal Liver Metastases.
Saadat L, Boerner T, Goldman D, Gonen M, Frankel T, Vakiani E
Ann Surg Oncol. 2020; 28(2):817-825.
PMID: 32683635
PMC: 7854850.
DOI: 10.1245/s10434-020-08862-3.
Oncogenic Signaling Alters Cell Shape and Mechanics to Facilitate Cell Division under Confinement.
Matthews H, Ganguli S, Plak K, Taubenberger A, Win Z, Williamson M
Dev Cell. 2020; 52(5):563-573.e3.
PMID: 32032547
PMC: 7063569.
DOI: 10.1016/j.devcel.2020.01.004.
Ras functional proximity proteomics establishes mTORC2 as new direct ras effector.
Kovalski J, Shanderson R, Khavari P
Oncotarget. 2019; 10(50):5126-5135.
PMID: 31497244
PMC: 6718260.
DOI: 10.18632/oncotarget.27025.